Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Strategic Play: MarketAxess Gains Majority Control of RFQ-hub
Strategic Play: MarketAxess Gains Majority Control of RFQ-hub

MarketAxess Holdings Inc. MKTX recently acquired a majority stake in RFQ-hub Holdings LLC, a global request-for-quote (RFQ) platform that facilitates trading in ETFs, derivatives, and structured

3 Film & Television Production Stocks to Watch Amid Dull Industry Trends
3 Film & Television Production Stocks to Watch Amid Dull Industry Trends

The Zacks Film and Television Production and Distribution industry is witnessing a surge in demand for digital entertainment due to operational constraints faced by movie theaters, theme parks and

Ross Stores (ROST) Expected to Beat Earnings Estimates: Should You Buy?
Ross Stores (ROST) Expected to Beat Earnings Estimates: Should You Buy?

Ross Stores (ROST) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives

Workday (WDAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Workday (WDAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Workday (WDAY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is

StepStone Group Inc. (STEP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
StepStone Group Inc. (STEP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects StepStone Group Inc. (STEP) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Earnings Preview: Deckers (DECK) Q4 Earnings Expected to Decline
Earnings Preview: Deckers (DECK) Q4 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when Deckers (DECK) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Intuit (INTU) Reports Next Week: Wall Street Expects Earnings Growth
Intuit (INTU) Reports Next Week: Wall Street Expects Earnings Growth

Intuit (INTU) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a

Autodesk (ADSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Autodesk (ADSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Autodesk (ADSK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a

Analysts Estimate Advance Auto Parts (AAP) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Advance Auto Parts (AAP) to Report a Decline in Earnings: What to Look Out for

The market expects Advance Auto Parts (AAP) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Silvercorp (SVM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Silvercorp (SVM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Silvercorp (SVM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

Toronto-Dominion Bank (TD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Toronto-Dominion Bank (TD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on higher revenues when Toronto-Dominion Bank (TD) reports results for the quarter ended April 2025. While this widely-known consensus

Ralph Lauren (RL) Earnings Expected to Grow: Should You Buy?
Ralph Lauren (RL) Earnings Expected to Grow: Should You Buy?

The market expects Ralph Lauren (RL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

BJ's Wholesale Club (BJ) Earnings Expected to Grow: Should You Buy?
BJ's Wholesale Club (BJ) Earnings Expected to Grow: Should You Buy?

The market expects BJ's Wholesale Club (BJ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus

Toyota Q4 Earnings Surpass Estimates but Decline Year Over Year
Toyota Q4 Earnings Surpass Estimates but Decline Year Over Year

Toyota TM reported fiscal fourth-quarter 2025 earnings per share of $3.39, which surpassed the Zacks Consensus Estimate of $2.92 but declined from the year-ago quarter’s earnings of $4.99

ETFs to Capitalize on the Novo Nordisk-Septerna Deal
ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market.  Following the

HMC Q4 Earnings Miss, FY26 View Downbeat Amid Tariff Woes
HMC Q4 Earnings Miss, FY26 View Downbeat Amid Tariff Woes

Honda HMC reported earnings of 18 cents per share for fourth-quarter fiscal 2025, missing the Zacks Consensus Estimate of 72 cents. The bottom line also declined from the year-ago profit of 99 cents

Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect?
Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect?

Shares of NovoCure (NVCR) have gained 8% over the past four weeks to close the last trading session at $17.10, but there could still be a solid upside left in the stock if short-term price targets

Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet
Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet

MoonLake Immunotherapeutics (MLTX) closed the last trading session at $36.99, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 408.63% Upside in Intellia Therapeutics (NTLA): Can the Stock Really Move This High?
Wall Street Analysts See a 408.63% Upside in Intellia Therapeutics (NTLA): Can the Stock Really Move This High?

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 14.9% over the past four weeks to close the last trading session at $7.88, but there could still be a solid upside left in the stock if

Wall Street Analysts Think Dream Finders Homes (DFH) Could Surge 26.83%: Read This Before Placing a Bet
Wall Street Analysts Think Dream Finders Homes (DFH) Could Surge 26.83%: Read This Before Placing a Bet

Dream Finders Homes Inc. (DFH) closed the last trading session at $23.26, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?
Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?

AtriCure (ATRC) closed the last trading session at $32.25, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade
Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade

Arcturus Therapeutics (ARCT) closed the last trading session at $10.84, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Does Enanta Pharmaceuticals (ENTA) Have the Potential to Rally 189.58% as Wall Street Analysts Expect?
Does Enanta Pharmaceuticals (ENTA) Have the Potential to Rally 189.58% as Wall Street Analysts Expect?

Shares of Enanta Pharmaceuticals (ENTA) have gained 5.1% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term

How Much Upside is Left in Ivanhoe Electric (IE)? Wall Street Analysts Think 105.88%
How Much Upside is Left in Ivanhoe Electric (IE)? Wall Street Analysts Think 105.88%

Ivanhoe Electric (IE) closed the last trading session at $6.80, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict a 78.84% Upside in QuinStreet (QNST): Here's  What You Should Know
Wall Street Analysts Predict a 78.84% Upside in QuinStreet (QNST): Here's What You Should Know

QuinStreet (QNST) closed the last trading session at $15.88, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall